TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that it has completed its first production run and shipment of products to dispensaries in the State of Missouri. This marks the start of Heritage product sales in the second state in the United States, with products now available in both Missouri and West Virginia. Products available to purchase in the U.S. include RAD distillate vapes, RAD live resin and live rosin, with additional products in the pipeline including pre-rolls and blunt, infused pre-rolls and blunts as well as concentrate dispensers.
This is the second milestone achievement in Heritage’s U.S. strategic plan, and with further expansion into additional states on the horizon, we are poised to capture market share with our established brands and formulations. Heritage commenced operations in the state of Missouri through a relationship with Como Health LLC, doing business as 3Fifteen Primo Cannabis (“3Fifteen”). 3Fifteen, a rapidly growing cannabis company with five dispensaries in operation, received an Approval to Operate from the Missouri Section for Medical Marijuana Regulation, and production on vape products and concentrates commenced in the State shortly after.
“With the recent successful legalization of cannabis in the state of Missouri we are thrilled to be ahead of the curve with products on shelves ready to serve both medical and recreational consumer groups in the State,” said David Schwede, CEO of Heritage. “Our U.S. strategy is adding a high gross margin revenue stream to the business using an asset light approach in partnership with existing local license holders, and as a market leader and innovator we continue to launch new products to capture a substantial share of early shelf space in these burgeoning markets.”
On December 8, 2022, recreational cannabis use became officially legal in Missouri, a move that is expected to significantly expand the market. This is in addition to the medical marijuana program that was approved in 2018. With legalization in force, MJBizDaily projects sales could reach up to US$550 million in Missouri in the first year of legalization and as much as US$900 million by year four. In comparison, the Canadian cannabis market size where Heritage currently operates is US$3.4 billion in 2022 according to MJBizDaily, making the Missouri market potential approximately 25% of the entire Canadian market.
About Heritage Cannabis Holdings Corp.
Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the U.S.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.
“David Schwede”
David Schwede, CEO
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.
Contacts
For more information:
Kelly Castledine
Tel: 647-660-2560
Company Relationship Disclosure
T420 is responsible for the T420 opinions provided in this disclosure except all sources or information provided by other parties were not verified or authenticated and T420 does not undertake to confirm or substantiate or be responsible for such information provided by other parties.
Any Content posted regarding a Profiled Issuer is not a solicitation or recommendation to buy, sell or hold securities. We cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. All information should be independently verified. We are not responsible for errors or omissions in our publications, and any opinions expressed are subject to change, without notice. We do not, nor are we under any obligation to undertake due diligence or investigation or authenticate and verify whatsoever regarding Profiled Issuers or any Content posted in relation thereto and we do not receive any verification from the Profiled Issuer regarding the Content we disseminate. Similarly, while we endeavor to facilitate the provision of quality information, we are not responsible for any loss or damages caused or alleged to have been caused by its use nor verify or authenticate or update such information.
Pursuant to an agreement between Spotlight Media Corp and Heritage Cannabis (CANN) we have been hired for a period of 90 days beginning December 1, 2022 and ending March 1, 2023 to publicly disseminate information about CANN including on the Website and other media including Facebook and Twitter. We are being paid $3,000 per month by CANN and were paid “ZERO” shares of unrestricted or restricted common shares. We plan to sell the “ZERO” shares of CANN that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of CANN in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
This article contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “expects”, “does not expect”, “is expected”, “believes”, “intends”, “anticipates”, “does not anticipate”, “believes” or variations of these words, expressions or statements, that certain actions, events or results “may”, “could”, “would”, “might” or “will be” taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, dependence on obtaining and maintaining regulatory approvals, including the acquisition and renewal of federal, provincial, state, municipal, local or other licenses, and any inability to obtain all necessary government authorizations, licenses and permits to operate and expand the Company’s facilities; regulatory or policy changes such as changes in applicable laws and regulations, including federal, state and provincial legalization, due to fluctuations in public opinion, industry perception of integrative mental health, including the use of psychedelic-assisted therapy, delays or inefficiencies or any other reason; any other factor or development likely to hamper the growth of the market; the Company’s limited operating and profitability track record; dependence on management; the Company’s need for additional financing and the effects of financial market conditions and other factors on the availability of capital; competition, including that of more established and better funded competitors; the impact of the Russia-Ukraine conflict on the global economy; the continued impact of the COVID-19 pandemic; and the need to build and maintain alliances and partnerships, including with research and development companies, customers and suppliers. These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company’s efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws.
Comments